AMLX
Amylyx Pharmaceuticals (AMLX) Investor Questions
Review Amylyx Pharmaceuticals (AMLX) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Amylyx Pharmaceuticals
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 49
- Annual revenue
- $87.37M
- Annual net income
- $-301.74M
- Annual free cash flow
- $-167.80M
Amylyx Pharmaceuticals (AMLX) Investor Questions research
Amylyx Pharmaceuticals trades under the ticker AMLX. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review AMLX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.